Strategic Overview

Pluslife develops MiniDock MTB, a near-point-of-care molecular test for TB diagnosis.

Innovation Portfolio

MiniDock MTB
Category: DIAGNOSIS Stage: Late Stage

Innovative diagnostic solution.

nPOC Molecular Swab/Sputum

Key Milestones

MiniDock MTB nPOC molecular test
Sputum sensitivity: 85.7%
ERPD approval status
Affordable pricing